Breaking Down The Costs Of Biogen's Billion-Dollar Alzheimer's Drug

Breaking down the costs of Biogen's billion-dollar Alzheimer's drug

CNBC Television

Biogen gets FDA approval for Alzheimer's drug Aduhelm which will cost $56,000 per year per patient

Evidence to approve Biogen's Alzheimer's drug was not 'sufficient': Penn's Dr. Jason Karlawi

CNBC Television

Cautious on Biogen's Alzheimer’s drug due to uncertainty around cost, reimbursement, access: Wedbush

CNBC Television

What’s The Controversy Behind Biogen’s Alzheimer’s Drug?

CNBC

This analyst breaks down the bull case for Biogen's Alzheimer's drug

CNBC Television

FDA approves controversial Biogen Alzheimer's drug | DW News

FDA approves Biogen Alzheimer's drug, first new therapy for the disease in nearly two decades

CNBC Television

Medicare Will Cover Cost Of Biogen's Alzheimer's Drug For Patients In Trials

FDA ‘abandoned its responsibility’ in approving Biogen Alzheimer’s drug: Doctor

Analyst on what Biogen's Alzheimer's drug means for the company

CNBC Television

Biogen CEO on FDA approval for its Alzheimer's drug

CNBC Television

What Biogen halted its Alzheimer's drug trial means for biotech investors

CNBC Television

Biogen's Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst

Biogen CEO to step down after Alzheimer's drug snags

Biogen reopens following FDA approval of company's Alzheimer drug

CNBC Television

Why this analyst remains a 'skeptic' on Biogen's new Alzheimer's drug

CNBC Television

FDA's historic approval of Biogen's Alzheimer's drug

CNBC Television

FDA approves Biogen Alzheimer's treatment

CNBC Television

United States approves first Alzheimer's drug in 18 years, Biogen's aducanumab | ABC News

ABC News (Australia)